Iandra Souza

Statistics

Publications

Citations

989

H-Index

Active since

2005

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Fondazione IRCCS Istituto Neurologico Carlo Besta

University of North Carolina at Chapel Hill

National Hospital Organization Hanamaki Hospital

Stanford University

Iandra Souza is an author at Alexion Pharmaceuticals (United States) specializing in myasthenia gravis, myasthenia gravis pharmacotherapy, and pharmacology.

Publications per year

2005–2020

Publications

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

The role of nitric oxide in the emotional learning of rats in the plus-maze

Isabel Cristina da Cunha, Rojan Jose, Lenir Orlandi Pereira et al. · Physiology & Behavior · 2005 · 31 citations

Life Sciences, Neurobiology, Neuroscience +12

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Hiroyuki Murai, Akiyuki Uzawa, Yasushi Suzuki et al. · Journal of the Neurological Sciences · 2019 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

1–5 of 5